View in EDS HTML Full Text PDF Full Text

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.

Saved in:
Bibliographic Details
Title: Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
Authors: Harrington, Kevin J1 (AUTHOR) kevin.harrington@icr.ac.uk, Soulières, Denis2 (AUTHOR), Tourneau, Christophe Le3,4,5 (AUTHOR), Dinis, Jose6 (AUTHOR), Licitra, Lisa F7 (AUTHOR), Ahn, Myung-Ju8 (AUTHOR), Soria, Ainara9 (AUTHOR), Machiels, Jean-Pascal H10 (AUTHOR), Mach, Nicolas11 (AUTHOR), Mehra, Ranee12 (AUTHOR), Burtness, Barbara13 (AUTHOR), Ellison, Misoo C14 (AUTHOR), Cheng, Jonathan D14 (AUTHOR), Chirovsky, Diana Romana14 (AUTHOR), Swaby, Ramona F14 (AUTHOR), Cohen, Ezra E W15 (AUTHOR), Le Tourneau, Christophe16,17,18 (AUTHOR)
Source: JNCI: Journal of the National Cancer Institute. Feb2021, Vol. 113 Issue 2, p171-181. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00278874
DOI:10.1093/jnci/djaa063